Autoantibody Biomarker Discovery
- Identification of autoantibody biomarker signatures
Response Prediction
- Predict responders, non-responders and those at risk for adverse events
Patient Stratification
- Intra disease stratification, identification of cohorts and clinical trial patient enrichment
Companion Diagnostic Development
- Establish biomarker signatures for companion diagnostic development


High-throughput autoantibody profiling against 1600+ proteins
Quantification of autoantibodies to 200+ clinically relevant CT antigens
Simultaneous screening of 100+
wild-type and mutant p53
Multi-antigen, multi-domain
COVID-19 antibody test